Clinical trial
A Multicentre Randomised Placebo-Controlled Trail of Ibuprofen for the Prevention of Ectopic Bone-Related Pain and Disability After Elective Hip Replacement Surgery (HIPAID)
NCT00145730 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicentre Randomised Placebo-Controlled Trail of Ibuprofen for the Prevention of Ectopic Bone-Related Pain and Disability After Elective Hip Replacement Surgery (HIPAID)
- Lead sponsor
- The George Institute
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2002
- Completion date
- May 31, 2004
- Enrollment
- 1,000
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
arthritis, rheumatoid, arthroplasty, replacement, hip, osteoarthritis, hip